Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians

Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study

Efficacy of 308-nm excimer laser for primary localized cutaneous amyloidosis treatment in Asians, pilot study.

Inclusion Criteria:

• Patients, aged >18 years old with lichen amyloidosis diagnosed by using clinical presentation and pathologic features

Exclusion Criteria:

• Those with cutaneous amyloidosis associated systemic diseases
• Pregnancy or lactating woman
• Those who are allergic to urea, olive oil
• Those who are photosensitive to ultraviolet radiation
• Those who had been previously treated with medications/ radiation/ laser within 3 months for systemic and 1 month for topical therapy